Next Article in Journal
Changes in Lutein Status Markers (Serum and Faecal Concentrations, Macular Pigment) in Response to a Lutein-Rich Fruit or Vegetable (Three Pieces/Day) Dietary Intervention in Normolipemic Subjects
Previous Article in Journal
Skin Manifestations and Coeliac Disease in Paediatric Population
 
 
Reply published on 18 October 2021, see Nutrients 2021, 13(10), 3639.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Comment

Comment on Moriconi et al. Very-Low-Calorie Ketogenic Diet as a Safe and Valuable Tool for Long-Term Glycemic Management in Patients with Obesity and Type 2 Diabetes. Nutrients 2021, 13, 758

by
Kirsten A. Berk
*,
Elles J. T. M. van der Louw
,
Joanne F. Olieman
and
Aart J. van der Lely
Department of Internal Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
*
Author to whom correspondence should be addressed.
Nutrients 2021, 13(10), 3613; https://doi.org/10.3390/nu13103613
Submission received: 30 June 2021 / Accepted: 9 October 2021 / Published: 15 October 2021
With interest, we have read the article of Moriconi et al. [1] entitled “Very-Low-Calorie Ketogenic Diet as a Safe and Valuable Tool for Long-Term Glycemic Management in Patients with Obesity and Type 2 Diabetes”. A very low carbohydrate ketogenic diet (VLCHKD; <10% energy from CHO/day) is a popular, often effective dietary intervention for people with obesity related-type 2 diabetes mellitus (T2DM) [2,3,4,5,6]. However, ketogenic diets applied in T2DM studies differ significantly in nutrient composition (different percentages of carbohydrate, protein, fat and types of fatty acids), resulting in a heterogeneity that influences reproducibility and interpretation of their results.
Moriconi et al. [1], did not provide data on the nutritional composition of the VLCHKD during the study period, making the interpretation and translation of the results into everyday practice difficult. Furthermore, the title of the paper indicates that ketosis was reached, but data on the achieved ketosis are not presented. As studies among adults with diabetes often opt for a diet with a ratio of fat to carbohydrates and protein of no more than 1:1, the question is whether substantial ketosis actually occurred during the intervention in the study of Moriconi and co-workers. This is in contrast to diets used, e.g., in children with epilepsy, in which ratios of 3:1 and higher are often achieved, resulting in a considerable level of ketosis [7,8].
In addition, we have some concerns about the methodology used in the study by Moriconi et al. [1]. First of all, the significant differences in baseline anthropometric measures between the cohorts certainly influence the results. For example, the VLCHKD group had 20 kg more excess in bodyweight and thus presumably this cohort had a higher motivation and potential for improvement. It is also unclear whether participants were free to choose the dietary intervention. Moreover, details on the time period in which the data from the historical cohort were collected are missing.
The use of VLCHKDs is an important and promising area of research in obesity-related T2DM. However, interpretation of the available published results is currently hampered by differences in diet composition, incomplete reporting of diet composition, and differences in nomenclature as also indicated by Trimboli et al. [9]. We therefore strongly advocate a consensus on these issues in the field of obesity-related T2DM in order to improve the quality of study designs, interpretation and reproducibility of data. Although the results reported by Moriconi et al. [1] are of interest, we believe that they should be interpreted with caution.

Author Contributions

K.A.B., E.J.T.M.v.d.L., J.F.O., A.J.v.d.L.; writing—original draft preparation, K.A.B., E.J.T.M.v.d.L.; writing—review and editing, K.A.B., E.J.T.M.v.d.L., J.F.O., A.J.v.d.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Moriconi, E.; Camajani, E.; Fabbri, A.; Lenzi, A.; Caprio, M. Very-Low-Calorie Ketogenic Diet as a Safe and Valuable Tool for Long-Term Glycemic Management in Patients with Obesity and Type 2 Diabetes. Nutrients 2021, 13, 758. [Google Scholar] [CrossRef] [PubMed]
  2. van Zuuren, E.J.; Fedorowicz, Z.; Kuijpers, T.; Pijl, H. Effects of low-carbohydrate- compared with low-fat-diet interventions on metabolic control in people with type 2 diabetes: A systematic review including GRADE assessments. Am. J. Clin. Nutr. 2018, 108, 300–331. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Korsmo-Haugen, H.-K.; Brurberg, K.G.; Mann, J.; Aas, A.-M. Carbohydrate quantity in the dietary management of type 2 diabetes: A systematic review and meta-analysis. Diabetes, Obes. Metab. 2018, 21, 15–27. [Google Scholar] [CrossRef] [PubMed]
  4. McArdle, P.D.; Greenfield, S.M.; Rilstone, S.K.; Narendran, P.; Haque, M.S.; Gill, P.S. Carbohydrate restriction for glycaemic control in Type 2 diabetes: A systematic review and meta-analysis. Diabet. Med. 2019, 36, 335–348. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Sainsbury, E.; Kizirian, N.V.; Partridge, S.R.; Gill, T.; Colagiuri, S.; Gibson, A.A. Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: A systematic review and meta-analysis. Diabetes Res. Clin. Pract. 2018, 139, 239–252. [Google Scholar] [CrossRef] [PubMed]
  6. Goldenberg, J.Z.; Day, A.; Brinkworth, G.D.; Sato, J.; Yamada, S.; Jönsson, T.; Beardsley, J.; Johnson, J.A.; Thabane, L.; Johnston, B.C. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: Systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 2021, 372, m4743. [Google Scholar] [CrossRef] [PubMed]
  7. Klepper, J.; Leiendecker, B. Glut1 Deficiency Syndrome and Novel Ketogenic Diets. J. Child Neurol. 2013, 28, 1045–1048. [Google Scholar] [CrossRef] [PubMed]
  8. Longo, R.; Peri, C.; Cricrì, D.; Coppi, L.; Caruso, D.; Mitro, N.; De Fabiani, E.; Crestani, M. Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry. Nutrients 2019, 11, 2497. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Trimboli, P.; Castellana, M.; Bellido, D.; Casanueva, F.F. Confusion in the nomenclature of ketogenic diets blurs evidence. Rev. Endocr. Metab. Disord. 2020, 21, 1–3. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Berk, K.A.; van der Louw, E.J.T.M.; Olieman, J.F.; van der Lely, A.J. Comment on Moriconi et al. Very-Low-Calorie Ketogenic Diet as a Safe and Valuable Tool for Long-Term Glycemic Management in Patients with Obesity and Type 2 Diabetes. Nutrients 2021, 13, 758. Nutrients 2021, 13, 3613. https://doi.org/10.3390/nu13103613

AMA Style

Berk KA, van der Louw EJTM, Olieman JF, van der Lely AJ. Comment on Moriconi et al. Very-Low-Calorie Ketogenic Diet as a Safe and Valuable Tool for Long-Term Glycemic Management in Patients with Obesity and Type 2 Diabetes. Nutrients 2021, 13, 758. Nutrients. 2021; 13(10):3613. https://doi.org/10.3390/nu13103613

Chicago/Turabian Style

Berk, Kirsten A., Elles J. T. M. van der Louw, Joanne F. Olieman, and Aart J. van der Lely. 2021. "Comment on Moriconi et al. Very-Low-Calorie Ketogenic Diet as a Safe and Valuable Tool for Long-Term Glycemic Management in Patients with Obesity and Type 2 Diabetes. Nutrients 2021, 13, 758" Nutrients 13, no. 10: 3613. https://doi.org/10.3390/nu13103613

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop